ARTICLE | Clinical News
Ensituximab: Phase I/IIa data
June 10, 2013 7:00 AM UTC
Preliminary data from 17 evaluable patients with advanced pancreatic and colorectal cancer who progressed on standard therapy in the Phase IIa portion of an open-label, U.S. Phase I/IIa trial showed t...